Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v1-EN
Language French English
Date Updated 2017-08-02 2017-07-19
Drug Identification Number 02360810 02360810
Brand name SPRYCEL SPRYCEL
Common or Proper name dasatinib dasatinib
Company Name BRISTOL-MYERS SQUIBB CANADA BRISTOL-MYERS SQUIBB CANADA
Ingredients DASATINIB DASATINIB
Strength(s) 80MG 80MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 1 BTL X 30 1 BTL X 30
ATC code L01XE L01XE
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2017-08-04 2017-08-07
Actual start date
Estimated end date 2017-08-04 2017-08-16
Actual end date 2017-08-03
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments Product on allocation, other strengths are available. Product on allocation, other strengths are available.
Health Canada comments